Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
England
London hospital pilots Apple Watch for chemo patients
By
Jonah Comstock
|
09:09 am |
May 14, 2015
Correction: This article previously mentioned strategic investors in MedoPad.
Still facing FDA opposition in the US, 23andMe heads across the pond
By
Jonah Comstock
|
08:46 am |
December 02, 2014
Google-backed 23andMe is finally relaunching its mail-order personal genome service -- just not in the United States.